CASP10 and Familial prostate cancer: In present study, we newly showed that caspase-10 was dispensable for realization of the cytotoxic potential of the cisplatin/LA-12 and TRAIL combination in prostate cancer cells, and also did not significantly affect the drug-induced Bid cleavage.